NewslettersMammary Cell News Targeting EMSY-Mediated Methionine Metabolism Is a Potential Therapeutic Strategy for Triple-Negative Breast Cancer By lbeveridge - January 31, 2024 0 Researchers discovered that EMSY, inducing a BRCAness phenotype, was preferentially expressed in breast CSCs, promoted ALDH+ cells enrichment, and was positively correlated with poor relapse-free survival. [Cell Reports Medicine] Full ArticleGraphical Abstract